Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Verified Market Research | PRODUCT CODE: 1733398

Cover Image

PUBLISHER: Verified Market Research | PRODUCT CODE: 1733398

Perfusion Services Market By Type (Cardiopulmonary Bypass (CPB), Extracorporeal Membrane Oxygenation (ECMO), Isolated Limb Perfusion), Application (Hospitals, Clinics), & Region For 2026-2032

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF & Excel (5 User License)
USD 4850
PDF & Excel (Enterprise User License)
USD 7550

Add to Cart

Perfusion Services Market Valuation - 2026-2032

In the perfusion services market, the increased prevalence of chronic diseases such as cardiovascular and respiratory ailments is an important factor. These disorders frequently demand sophisticated surgical procedures including cardiopulmonary bypass or extracorporeal membrane oxygenation (ECMO) technologies. Perfusion services are essential in operating this equipment, guaranteeing optimal blood circulation and oxygenation during key procedures. The market size surpass USD 517.88 Million valued in 2024 to reach a valuation of around USD 703.7 Million by 2032.

The growing number of organ transplants is another important factor driving market expansion. Perfusionists are responsible for preserving organs throughout transportation and guaranteeing their viability for transplantation. With advances in organ preservation procedures and increased public awareness of organ donation, the demand for skilled perfusionists and their services is predicted to continuously increase. The rising demand for cost-effective and efficient perfusion services is enabling the market grow at a CAGR of 4.31% from 2026 to 2032.

Perfusion Services Market: Definition/ Overview

Perfusion services are the specialist medical specialty of delivering and managing extracorporeal circulation during surgical procedures, notably heart surgery. Perfusionists operate heart-lung machines and other equipment that temporarily replace the functions of the heart and lungs, allowing surgeons to do procedures on the heart or major blood vessels safely. Their principal function is to keep blood flow, oxygenation, and circulation in the patient's blood while the heart is stopped or the lungs are bypassed. Perfusion services are essential for maintaining patient stability and safety during complex surgeries such as coronary artery bypass grafting (CABG), valve replacements, and congenital heart defect repairs.

Perfusion services are now used in a variety of specializations beyond cardiac surgery, including organ transplantation, trauma surgery, and certain types of cancer treatment. Perfusionists play an important role in these situations because they specialize in controlling and optimizing blood flow and oxygen delivery to essential organs during critical procedures. Their abilities are critical in preserving patient hemodynamic stability and avoiding problems caused by prolonged periods of organ ischemia or hypoxia.

Perfusion services are projected to evolve further as medical technology and surgical practices progress. As healthcare systems around the world prioritize patient outcomes and cost-effectiveness, there is an increasing demand for perfusionists who can contribute to better surgical results, fewer complications, and faster recovery times. Perfusion services will likely become more integrated into multidisciplinary care teams, encouraging collaboration among perfusionists, surgeons, anesthesiologists, and other healthcare providers to enhance patient care pathways.

Will Increasing Cardiovascular Surgeries Drive the Perfusion Services Market?

In the perfusion services market, as the global population ages and lifestyles contribute to increased occurrences of cardiovascular diseases such as coronary artery disease and heart valve abnormalities, the demand for cardiac surgical interventions rises. Procedures such as coronary artery bypass grafting (CABG), heart valve repairs/replacements, and congenital heart defect corrections necessitate the knowledge of perfusionists to efficiently control extracorporeal circulation. Perfusionists work with heart-lung machines and monitor important physiological parameters to maintain proper blood flow, oxygenation, and metabolic balance during these difficult procedures. The increasing number of cardiovascular surgeries correlates directly with increased demand for perfusion services, emphasizing their critical role in improving surgical outcomes and patient recovery.

Furthermore, advances in medical technology and surgical procedures continue to broaden the rationale for cardiovascular surgery, making it safer and more accessible to a larger patient group. These developments include minimally invasive treatments as well as perfusion equipment innovations that increase cardiac surgery efficiency and outcomes. As healthcare systems strive to meet the growing healthcare needs of the world's aging population, the demand for perfusionists skilled in managing extracorporeal circulation during cardiovascular surgeries is expected to steadily rise, driving the growth of the perfusion services market in the coming years.

Will the High Cost of Equipment and Services Impact the Perfusion Services Market?

In the perfusion services market, the capital investment necessary to purchase, maintain, and upgrade complex perfusion equipment, such as heart-lung machines, oxygenators, and monitoring devices, is a significant financial hurdle for healthcare organizations. The initial cost of procuring this specialist equipment, together with continuous expenses for maintenance, calibration, and updates, can put a strain on hospital finances, especially in resource-limited settings or smaller healthcare facilities. This financial barrier may dissuade some institutions from investing in perfusion services or restrict their ability to extend existing programs, limiting market growth.

Furthermore, the high cost of perfusion services includes expenses such as staffing, training, and regulatory compliance. Recruiting and maintaining qualified perfusionists, who need extensive education and training, increases operational costs. Furthermore, meeting severe regulatory standards for patient safety and quality assurance requires continual investment in personnel training, certification processes, and compliance measures. These accumulated expenditures add to the overall economic constraints on healthcare providers providing perfusion services, potentially affecting their profitability and sustainability in the competitive healthcare market.

Addressing the dilemma of high equipment and service prices in the perfusion services industry necessitates novel techniques, such as collaborative purchasing agreements across hospital networks to negotiate better pricing with equipment vendors.

Category-Wise Acumens

Will Cardiopulmonary Bypass (CPB) Segment Propel the Growth of the Perfusion Services Market?

The Cardiopulmonary Bypass (CPB) segment is a key driver of growth in the perfusion services market. CPB is a critical component of cardiac surgery, allowing surgeons to temporarily bypass the heart and lungs while performing complex procedures like coronary artery bypass grafting (CABG) and valve replacements. Perfusionists play an important role in CPB management by controlling heart-lung machines, monitoring vital signs, and ensuring proper oxygenation and blood flow throughout the process.

As the global burden of cardiovascular disease grows and surgical techniques evolve, the demand for CPB operations is likely to climb. This trend not only highlights the need for perfusion services in cardiac surgery but also increases the demand for trained perfusionists and innovative perfusion technologies. As a result, the CPB category is expected to provide a substantial contribution to the growth and evolution of the perfusion services market in the coming years.

Cardiopulmonary bypass (CPB) now dominates the perfusion services market. This supremacy stems mostly from the widespread use of CPB technology in numerous cardiac operations. Procedures such as coronary artery bypass grafting (CABG) and valve replacements rely significantly on CPB to temporarily take over heart and lung functions, allowing surgeons to work in a still and bloodless environment. The high volume of these surgeries, along with the complexity of CPB technology, needs a professional perfusion staff to operate the bypass machine and provide the best possible patient results.

Will the Primary Healthcare Settings Drive the Growth of the Perfusion Services Market?

Primary healthcare settings are increasingly expected to fuel the growth of the perfusion services market. As healthcare systems worldwide try to improve patient care and surgical results, there is a rising emphasis on incorporating sophisticated perfusion services into primary and secondary care settings. This trend is driven by the need to deliver comprehensive cardiac treatment closer to home, thereby lowering the pressure on tertiary care centers and improving patient access to important services.

Furthermore, advances in perfusion technology and training have made it possible to expand these services to a broader range of healthcare settings, allowing more hospitals to execute difficult cardiac procedures with high levels of safety and efficacy. As a result, this expansion not only increases the availability of perfusion services, but it also encourages greater competition and innovation in the industry, promoting overall growth and development.

Although hospitals continue to dominate the perfusion services market, specialty cardiac and transplant clinics are expanding at a rapid pace. This spike can be linked to a few significant trends. First, there is an increasing emphasis on ambulatory care and minimally invasive surgical treatments. Complex cardiac procedures, which were previously performed in hospitals, are increasingly being performed in specialized clinics.

This transition demands professional perfusion support in these clinics. Second, the growth of specialized transplant centers dedicated to specific organs such as the heart, lungs, and kidneys is increasing demand for perfusion services inside these institutions. As these facilities seek the best patient outcomes, having readily available and highly qualified perfusionists becomes critical for successful transplant surgeries.

Country/Region-wise Acumens

Will Healthcare Infrastructure Drive the North American Region for the Growth of the Perfusion Services Market?

North America now dominates the perfusion services market. Healthcare infrastructure is a primary driver of the perfusion services market in North America. The well-established healthcare systems in nations such as the United States and Canada have a strong infrastructure to support modern medical treatments, such as cardiac operations that require perfusion. These countries have a dense network of hospitals, surgical centers, and specialty clinics equipped with cutting-edge technology and qualified healthcare staff, creating a favorable environment for the spread of perfusion services. The availability of specialist cardiac centers and comprehensive cardiovascular programs increases the demand for perfusionists who can perform cardiopulmonary bypass (CPB) during difficult surgical procedures.

Furthermore, continued investments in healthcare infrastructure, such as facility expansions, surgical equipment updates, and medical technology improvements, help to drive the perfusion services market. These expenditures improve healthcare facilities' capacity and efficiency in providing high-quality cardiac care, increasing the use of perfusion services. Furthermore, the incorporation of perfusion services into multidisciplinary care teams and collaborative approaches among healthcare professionals strengthens their role in improving patient outcomes and supporting the overall growth trajectory of the perfusion services market in North America.

Will Rapid Economic Growth Drive the Asian Pacific Region for the Growth of the Perfusion Services Market?

The Asia Pacific area is becoming the fastest-growing market for perfusion services. As Asia Pacific countries see strong economic growth, healthcare spending and infrastructure investment rise in tandem. This rise enables the spread of specialist medical treatments, such as cardiac procedures that necessitate perfusion services. Rising incomes and expanding middle-class populations in countries such as China, India, and Southeast Asia help to increase access to healthcare services, fueling demand for modern medical treatments and surgeries.

Furthermore, economic expansion in the Asia-Pacific area promotes technological advancements and innovations in healthcare. Improved healthcare facilities, including contemporary surgical equipment and cutting-edge perfusion technologies, increase hospitals' ability to execute difficult cardiac treatments safely and successfully. The demand for perfusionists skilled in managing cardiopulmonary bypass (CPB) during surgeries such as coronary artery bypass grafting (CABG) and heart valve replacements is expected to rise in tandem, establishing the Asia Pacific region as a key growth area for the perfusion services market in the coming years.

Competitive Landscape

The perfusion services market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the perfusion services market include:

  • SpecialtyCare
  • Keystone Perfusion Services, P.C.
  • Procirca
  • Vivacity Perfusio
  • Perfusion Solution, Inc.
  • Cambridge Perfusion Services

Latest Developments

  • In August 2023, The Journal of Thoracic and Cardiovascular Surgery released a research paper that presented encouraging outcomes from a clinical trial utilizing artificial intelligence-driven perfusion management technologies. The European study showed how artificial intelligence (AI) algorithms could help perfusionists optimize blood flow during complex cardiac procedures, which could lead to better patient outcomes.
  • In October 2023, A group of medical facilities and IT firms declared that they would work together to create standard operating procedures for point-of-care perfusion devices in emergency scenarios. This project demonstrates the increasing interest in increasing the accessibility of these portable technologies and their potential to enhance essential perfusion assistance in remote areas.
Product Code: 70027

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 MARKET DEFINITION
  • 1.2 MARKET SEGMENTATION
  • 1.3 RESEARCH TIMELINES
  • 1.4 ASSUMPTIONS
  • 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 DATA MINING
  • 2.2 SECONDARY RESEARCH
  • 2.3 PRIMARY RESEARCH
  • 2.4 SUBJECT MATTER EXPERT ADVICE
  • 2.5 QUALITY CHECK
  • 2.6 FINAL REVIEW
  • 2.7 DATA TRIANGULATION
  • 2.8 BOTTOM-UP APPROACH
  • 2.9 TOP DOWN APPROACH
  • 2.1 RESEARCH FLOW
  • 2.11 DATA SOURCES

3 EXECUTIVE SUMMARY

  • 3.1 MARKET OVERVIEW
  • 3.2 GLOBAL PERFUSION SERVICES MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
  • 3.3 GLOBAL PERFUSION SERVICES MARKET, BY TYPE (USD MILLION)
  • 3.4 GLOBAL PERFUSION SERVICES MARKET, BY APPLICATION (USD MILLION)
  • 3.5 FUTURE MARKET OPPORTUNITIES
  • 3.6 GLOBAL MARKET SPLIT

4 MARKET OUTLOOK

  • 4.1 GLOBAL PERFUSION SERVICES MARKET OUTLOOK
  • 4.2 MARKET DRIVERS
    • 4.2.1 INCREASING NUMBER OF CHRONIC DISEASES CASES IN THE WORLD
    • 4.2.2 GROWING NUMBER OF ORGAN TRANSPLANTATIONS
  • 4.3 MARKET RESTRAINT
    • 4.3.1 HIGH COST OF ORGAN TRANSPLANTATIONS PROCEDURE AND INADEQUATE INSURANCE COVERAGE
  • 4.4 MARKET OPPORTUNITIES
    • 4.4.1 INCREASING PHARMACEUTICAL R&D ACTIVITIES
  • 4.5 IMPACT OF COVID -19 ON CRYPTOCURRENCY MINING MACHINES MARKET

5 MARKET, BY TYPE

  • 5.1 OVERVIEW
  • 5.1 CARDIOPULMONARY BYPASS (CPB)
  • 5.2 EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
  • 5.3 ISOLATED LIMB PERFUSION

6 MARKET, BY APPLICATION

  • 6.1 OVERVIEW
  • 6.2 HOSPITALS
  • 6.3 CLINICS
  • 6.4 OTHERS

7 MARKET, BY GEOGRAPHY

  • 7.1 OVERVIEW
  • 7.2 NORTH AMERICA
    • 7.2.1 U.S
    • 7.2.2 CANADA
    • 7.2.3 MEXICO
  • 7.3 EUROPE
    • 7.3.1 GERMANY
    • 7.3.2 UK
    • 7.3.3 FRANCE
    • 7.3.4 ITALY
    • 7.3.5 RUSSIA
    • 7.3.6 REST OF EUROPE
  • 7.4 ASIA PACIFIC
    • 7.4.1 CHINA
    • 7.4.2 JAPAN
    • 7.4.3 INDIA
    • 7.4.4 SOUTH KOREA
    • 7.4.5 AUSTRALIA
    • 7.4.6 REST OF ASIA-PACIFIC
  • 7.5 REST OF THE WORLD
    • 7.5.1 MIDDLE EAST AND AFRICA
    • 7.5.2 LATIN AMERICA

8 COMPETITIVE LANDSCAPE

  • 8.1 OVERVIEW
  • 8.2 COMPANY RANKING ANALYSIS

9 COMPANY PROFILES

  • 9.1 SPECIALTYCARE
    • 9.1.1 COMPANY OVERVIEW
    • 9.1.2 PRODUCT BENCHMARKING
    • 9.1.3 KEY DEVELOPMENT
    • 9.1.4 SWOT ANALYSIS.
  • 9.2 KEYSTONE PERFUSION SERVICES, P.C.
    • 9.2.1 COMPANY OVERVIEW
    • 9.2.2 PRODUCT BENCHMARKING
    • 9.2.3 SWOT ANALYSIS.
  • 9.3 PROCIRCA
    • 9.3.1 COMPANY OVERVIEW
    • 9.3.2 PRODUCT BENCHMARKING
    • 9.3.3 SWOT ANALYSIS.
  • 9.4 VIVACITY PERFUSION
    • 9.4.1 COMPANY OVERVIEW
    • 9.4.2 PRODUCT BENCHMARKING
  • 9.5 PERFUSION SOLUTION, INC.
    • 9.5.1 COMPANY OVERVIEW
    • 9.5.2 COMPANY INSIGHTS
    • 9.5.3 PRODUCT BENCHMARKING
  • 9.6 CAMBRIDGE PERFUSION SERVICES
    • 9.6.1 COMPANY OVERVIEW
    • 9.6.2 COMPANY INSIGHTS.
    • 9.6.3 PRODUCT BENCHMARKING
  • 9.7 CIRCULATORY SERVICES INC.
    • 9.7.1 COMPANY OVERVIEW
    • 9.7.2 PRODUCT BENCHMARKING
  • 9.8 COMPREHENSIVE CARE SERVICES, INC.
    • 9.8.1 COMPANY OVERVIEW
    • 9.8.2 PRODUCT BENCHMARKING
  • 9.9 PALO ALTO PERFUSION SERVICES
    • 9.9.1 COMPANY OVERVIEW
    • 9.9.2 PRODUCT BENCHMARKING
Product Code: 70027

LIST OF TABLES

  • TABLE1 GLOBAL PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 2 GLOBAL PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 3 GLOBAL PERFUSION SERVICES MARKET, BY GEOGRAPHY, 2018 - 2027 (USD MILLION)
  • TABLE 4 NORTH AMERICA PERFUSION SERVICES MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 5 NORTH AMERICA PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 6 NORTH AMERICA PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 7 U.S. PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 8 U.S. PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 9 CANADA PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE10 CANADA PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE11 MEXICO PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE12 MEXICO PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE13 EUROPE PERFUSION SERVICES MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE14 EUROPE PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE15 EUROPE PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE16 GERMANY PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE17 GERMANY PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE18 UK PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE19 UK PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 20 FRANCE PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 21 FRANCE PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 22 ITALY PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 23 ITALY PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 24 RUSSIA PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 25 RUSSIA PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 26 REST OF EUROPE PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 27 REST OF EUROPE PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 28 ASIA PACIFIC PERFUSION SERVICES MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 29 ASIA PACIFIC PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 30 ASIA PACIFIC PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 31 CHINA PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 32 CHINA PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 33 JAPAN PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 34 JAPAN PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 35 INDIA PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 36 INDIA PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 37 SOUTH KOREA PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 38 SOUTH KOREA PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 39 AUSTRALIA PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 40 AUSTRALIA PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 41 REST OF ASIA-PACIFIC PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 42 REST OF ASIA-PACIFIC PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 43 ROW PERFUSION SERVICES MARKET, BY REGION, 2018 - 2027 (USD MILLION)
  • TABLE 44 ROW PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 45 ROW PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 46 MIDDLE EAST AND AFRICA PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 47 MIDDLE EAST AND AFRICA PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 48 LATIN AMERICA PERFUSION SERVICES MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 49 LATIN AMERICA PERFUSION SERVICES MARKET, BY APPLICATION, 2018 - 2027 (USD MILLION)
  • TABLE 50 SPECIALTYCARE: PRODUCT BENCHMARKING
  • TABLE 51 SPECIALTYCARE: KEY DEVELOPMENT
  • TABLE 52 KEYSTONE PERFUSION SERVICES, P.C.: PRODUCT BENCHMARKING
  • TABLE 53 PROCIRCA: PRODUCT BENCHMARKING
  • TABLE 54 VIVACITY PERFUSION: PRODUCT BENCHMARKING
  • TABLE 55 PERFUSION SOLUTION, INC.: PRODUCT BENCHMARKING
  • TABLE 56 CAMBRIDGE PERFUSION LLP: PRODUCT BENCHMARKING
  • TABLE 57 CIRCULATORY SERVICES INC.: PRODUCT BENCHMARKING
  • TABLE 58 COMPREHENSIVE CARE SERVICES, INC.: PRODUCT BENCHMARKING
  • TABLE 59 PALO ALTO PERFUSION SERVICES: PRODUCT BENCHMARKING

LIST OF FIGURES

  • FIGURE1 GLOBAL PERFUSION SERVICES MARKET SEGMENTATION
  • FIGURE 2 RESEARCH TIMELINES
  • FIGURE 3 DATA TRIANGULATION
  • FIGURE 4 MARKET RESEARCH FLOW
  • FIGURE 5 DATA SOURCES
  • FIGURE 6 GLOBAL PERFUSION SERVICES MARKET OVERVIEW
  • FIGURE 7 GLOBAL PERFUSION SERVICES MARKET GEOGRAPHICAL ANALYSIS, 2020-2027
  • FIGURE 8 GLOBAL PERFUSION SERVICES MARKET, BY TYPE (USD MILLION)
  • FIGURE 9 GLOBAL PERFUSION SERVICES MARKET, BY APPLICATION (USD MILLION)
  • FIGURE10 FUTURE MARKET OPPORTUNITIES
  • FIGURE11 NORTH AMERICA DOMINATED THE MARKET IN 2019
  • FIGURE12 GLOBAL PERFUSION SERVICES MARKET OUTLOOK
  • FIGURE13 GLOBAL PERFUSION SERVICES MARKET, BY TYPE
  • FIGURE14 GLOBAL PERFUSION SERVICES MARKET, BY APPLICATION
  • FIGURE15 GLOBAL PERFUSION SERVICES MARKET, BY GEOGRAPHY, 2018 - 2027 (USD MILLION)
  • FIGURE16 NORTH AMERICA MARKET SNAPSHOT
  • FIGURE17 EUROPE MARKET SNAPSHOT
  • FIGURE18 ASIA PACIFIC MARKET SNAPSHOT
  • FIGURE19 ROW MARKET SNAPSHOT
  • FIGURE 20 SPECIALTYCARE: SWOT ANALYSIS
  • FIGURE 21 KEYSTONE PERFUSION SERVICES, P.C.: SWOT ANALYSIS
  • FIGURE 22 PROCIRCA: SWOT ANALYSIS
  • FIGURE 23 PERFUSION SOLUTION, INC.: COMPANY INSIGHT
  • FIGURE 24 CAMBRIDGE PERFUSION LLP: COMPANY INSIGHT
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!